After two years of internal restructuring, Inserm U1070 is pleased to announce that it has obtained ISO 9001:2015 certification for its quality management system. This certification process began within the unit in 2014, with the initial certification of our bioanalysis skills, followed by the extension of the scope to include microbiology in 2018. This new recognition now covers all preclinical pharmacology research activities carried out within the unit. It attests to our ability to produce robust and reproducible scientific results within a structured and controlled methodological framework.

This certification highlights the strength of our internal operations, our mastery of our processes, and the constant involvement of all our staff in a shared quality approach. It also reflects our commitment to placing continuous improvement, traceability, and the satisfaction of our institutional, academic, and industrial partners at the heart of our practices.

For Inserm U1070, obtaining ISO 9001 certification helps strengthen the credibility of our preclinical research activities, ensures the long-term structuring of our working methods, and consolidates the relationships of trust established with our partners. This achievement fully aligns with our commitment to open, rigorous, transparent, and responsible research.

This certification marks the beginning of a new phase for our unit, focused on sustaining and continuously enhancing our quality approach, in support of scientific excellence and innovation in preclinical research.